Log in to search using one of your social media accounts:

 

Symptom management in women undergoing the menopause.

This article outlines the symptoms of the menopause and the available treatments for these, including hormone replacement therapy, non-hormonal treatments and alternative therapies, and discusses how nurses can assist women undergoing the menopause to improve their health and quality of life during this often challenging time. PMID: 29363891 [PubMed - in process]
Source: Nursing Standard - Category: Nursing Authors: Tags: Nurs Stand Source Type: research

Related Links:

There is a global trend that the average onset age of many human complex diseases is decreasing, and the age of cancer patients becomes more spread out. The age effect on survival is nonlinear in practice and may have one or more important change‐points at which the trend of the effect can be very different before and after these threshold ages. Identification of these change‐points allows clinical researchers to understand the biologic basis for the complex relation between age and prognosis for optimal prognostic decision. This paper considers estimation of the potentially nonlinear age effect for general partly line...
Source: Statistics in Medicine - Category: Statistics Authors: Tags: RESEARCH ARTICLE Source Type: research
This guidance pulls together the latest information on how menopause affects some women at work. It is aimed at women going through menopause and offers employers practical guidance on how to improve workplace environments for them.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
The objective of our prospective study is to specify the variability of densitometric response to Denosumab, given in the second line, and to try to understand the reasons. All menopausal patients with primary osteoporosis, treated by Denosumab in our centre from 2014 to 2015, were included in this open prospective work. At T0, the patient ’s age, type of fracture, and previous treatments were collated. At T0 and T1, after 1 year of treatment by Dmab, a DXA of the spine and the hip and a determination of CTX were performed. Sixty-three patients aged 68.8 ± 8.3 years were included. The median...
Source: Rheumatology International - Category: Rheumatology Source Type: research
No abstract available
Source: Menopause - Category: OBGYN Tags: Editorials Source Type: research
No abstract available
Source: Menopause - Category: OBGYN Tags: Editorials Source Type: research
No abstract available
Source: Menopause - Category: OBGYN Tags: Editorials Source Type: research
AbstractObjective:To assess the impact of discontinuing oral hormone therapy (HT) on sexual activity, vaginal symptoms, and sexual activity components among participants in the estrogen-progestin therapy (EPT) and estrogen therapy (ET) trial of the Women's Health Initiative.Methods:Surveys were sent postintervention to those who were still taking study pills and agreed to continue in the study when the trials were stopped. Comparisons between former HT and placebo users were accomplished with chi-square tests for categorical variables and t tests for continuous variables.Results:In all, 13,902 women with mean age at survey...
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
Conclusions:These findings provide a national estimate of ANM in Canada and show the importance of lifestyle factors and health conditions in determining menopausal age. These factors might help in risk assessment, prevention and early management of chronic disease risk during the menopausal transition. Background: Early onset of menopause is associated with long-term disease and higher mortality risks. Research suggests that age at natural menopause (ANM) varies across populations. Little is known about factors that affect ANM in Canadian women. Objective: This study aims to estimate the median ANM and examine fact...
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
AbstractObjective:The aim of the study was to explore dose-related endometrial effects of conjugated estrogens/bazedoxifene (CE/BZA).Methods:In this randomized, double-blind, phase 2 study, 408 nonhysterectomized, symptomatic (with hot flushes [HFs]) postmenopausal women received ≥1 dose of CE 0.3 or 0.625 mg alone or with BZA 5, 10, or 20 mg/d; placebo; BZA 5 mg/d alone; or CE 0.625 mg with medroxyprogesterone acetate 2.5 mg/d for 84 days. The primary outcome was endometrial thickness on transvaginal ultrasound. HF frequency and severity based on diaries were key secondary outcomes.Results:CE 0.625 mg alone...
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
Conclusions:In this qualitative study, women described experiencing both positive and negative changes in sexual function during midlife. When negative changes occurred, women often adapted behaviorally and psychologically. Providers should recognize that each woman's experience is unique and nuanced, and they should provide tailored care regarding sexual function at midlife. Objective: Women experience a variety of changes at midlife that may affect sexual function. Qualitative research approaches can allow a deeper understanding of women's experiences. We conducted 20 individual interviews and three focus groups amon...
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
More News: Alternative and Complementary Therapies | Complementary Medicine | Hormone Replacement Therapy | Hormones | Men | Menopause | Nurses | Nursing | Ovaries | Primary Care | Women